Skip to content

NMN for Immunosenescence: What the Evidence Actually Shows

Category: longevity | ICD-10: D89.9 | Evidence tier: mouse-only

What is Immunosenescence?

Immunosenescence is the age-related decline of the immune system, marked by weaker vaccine responses, more infections and chronic low-grade inflammation.

NMN relevance: the published evidence

Mouse studies show NAD+ supports immune cell metabolism. No human RCT has tested NMN with immune endpoints such as vaccine response or infection rate. Vaccination, sleep and protein adequacy remain proven supports.

Questions to ask before supplementing

No dose validated for immune outcomes.

Contraindications and red flags

Patients on immunosuppressants should consult their specialist before any new supplement.

Bottom line for Malaysian patients

NMN is not registered with NPRA as a treatment for any specific condition; it is sold as a general health supplement. If you have immunosenescence, use this page as a question list for a registered medical practitioner before adding NMN to existing therapy. Read our safety guide for full red-flag context.

Related conditions

Cited references